Drugs cost more when manufacturers sell directly to physicians, study says

(By Maia Anderson for Becker’s Hospital Review)

Drugmakers promoting their drugs directly to physicians affect prescribing quality and can raise drug prices, but the practice is more commonplace in smaller health systems with fewer physicians, according to a study published Jan. 27 in JAMA Internal Medicine.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.